Although further validation is necessary for generalization, these examples suggest that loss of TAAs, such as NECTIN4 and CLDN18.2, might occur in metastatic lesions owing to adaptation or plasticity of tumor cells in their metastatic niche. The gene discussed is NECTIN4; the disease is neoplasm.